Morgan Stanley
-
-
-
-
-
-
-
Acceleron Pharma (XLRN) PT Raised to $53 at Morgan Stanley
-
-
-
-
-
-
-
Acceleron Pharma (XLRN) PT Lowered to $42 at Morgan Stanley; 'Dalantercept Fails as the Market Anticipated'
-
-
-
-
-
-
-
Acceleron Pharma (XLRN) Plans $150M Common Stock Offering
-
-
-
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

